• June 1, 2020

ImmunSYS Announces Upcoming Presentation at AACR Virtual Annual Meeting II - Odessa American: Business

e-Edition Subscribe

ImmunSYS Announces Upcoming Presentation at AACR Virtual Annual Meeting II

Print
Font Size:
Default font size
Larger font size

Posted: Friday, May 15, 2020 7:01 am

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 15, 2020--

ImmunSYS, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products, today announced that results from a proof of concept (PoC) study evaluating its proprietary immunotherapy platform, YourVaccx TM, for the treatment of patients with metastatic solid tumor cancers will be presented at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II being held June 22 – 24.

The poster (#6540) entitled, “ Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series ” will be presented by Gary Onik, M.D.

ImmunSYS’s abstract can be found at https://www.abstractsonline.com/pp8/#!/9045/presentation/7023.

Following the presentation, a copy of the poster will be posted on www.immunsys.com.

About ImmunSYS

ImmunSYS, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with metastatic prostate cancer and other metastatic solid tumors.

ImmunSYS is committed to bringing life-changing treatments to patients with metastatic cancer. The Company’s platform technology, YourVaccx, empowers the immune system to generate a strong anticancer effect, potentially creating abscopal effects through the combination of cryosurgical cellular lysis and the intratumoral delivery of a proprietary triple-component immunotherapeutic drug that is in development.

The YourVaccx therapy has the potential to offer patients with metastatic solid tumors benefits over the existing standard of care. The company’s lead development program is the treatment of metastatic prostate cancer, followed by a pipeline of development programs for other metastatic solid tumors. For more information about the company and its programs, visit www.immunsys.com. Follow and connect with us on Twitter, Facebook, YouTube and LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements. Forward-looking statements can be identified by words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and other words and terms of similar meaning. The forward-looking statements contained in this news release include, but are not limited to, statements relating to future clinical results and the effectiveness of the company’s therapies. These forward-looking statements are subject to risks, uncertainties and other factors. Accordingly, actual results may differ significantly from those projected in the forward-looking statements contained herein. Readers should not place undue reliance on these forward-looking statements. The forward-looking statements included in this news release are made only as of the date hereof, and the company does not undertake any obligation to update any forward-looking statements to reflect subsequent events or circumstances, except as required by applicable law.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200515005207/en/

CONTACT: ImmunSYS, Inc.

Joseph Gerardi, +1-518-796-6110

Executive Vice President, Chief Financial Officer

jgerardi@immunsys.com

KEYWORD: FLORIDA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: ONCOLOGY HEALTH OTHER SCIENCE RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: ImmunSYS, Inc.

Copyright Business Wire 2020.

PUB: 05/15/2020 08:00 AM/DISC: 05/15/2020 08:01 AM

http://www.businesswire.com/news/home/20200515005207/en

© 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Partly Cloudy
82°
Humidity: 47%
Winds: ESE at 17mph
Feels Like: 83°

Your Extended Forecast

Tomorrow

weather
High 85°/Low 65°
Partly cloudy. Lows overnight in the mid 60s.

tuesday

weather
High 90°/Low 68°
Mostly sunny. Highs in the low 90s and lows in the upper 60s.

wednesday

weather
High 94°/Low 68°
Mix of sun and clouds. Highs in the mid 90s and lows in the upper 60s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.